Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sylvain Perruche

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
International Journal of Pharmaceutics|December 9, 2024
Clinically relevant cell culture model of inflammatory bowel diseases for identification of new therapeutic approachesThomas Antoine, Arnaud Béduneau, Claire Chrétien, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|March 14, 2024
Macrophage phenotype is determinant for fibrosis development in keloid diseaseZélie Dirand, Mélissa Maraux, Marion Tissot, et al.
Transplantation|February 24, 2006
Association of mixed hematopoietic chimerism with elevated circulating autoantibodies and chronic graft-versus-host disease occurrenceSylvain Perruche, Aliette Marandin, François Kleinclauss, et al.
Journal of Hematotherapy & Stem Cell Research|September 11, 2003
A single intravenous infusion of apoptotic cells, an alternative cell-based therapy approach facilitating hematopoietic cell engraftment, did not induce autoimmunitySylvain Perruche, François Kleinclauss, Régis Angonin, et al.
Arthritis Research & Therapy|July 3, 2009
Increased production of soluble CTLA-4 in patients with spondylarthropathies correlates with disease activityEric Toussirot, Philippe Saas, Marina Deschamps, et al.
Frontiers in Immunology|February 4, 2022
Pro-Resolving Factor Administration Limits Cancer Progression by Enhancing Immune Response Against Cancer CellsAudrey Wetzel, Francis Bonnefoy, Cécile Chagué, et al.
Blood|October 24, 2002
LF 15-0195 immunosuppressive agent enhances activation-induced T-cell death by facilitating caspase-8 and caspase-10 activation at the DISC levelPatrick Ducoroy, Olivier Micheau, Sylvain Perruche, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|March 6, 2004
[Tolerance in transplantation: potential contribution of haematopoietic transplantation and cell therapy]François Kleinclauss, Hugues Bittard, Sylvain Perruche, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 27, 2011
TGF-beta-exposed plasmacytoid dendritic cells participate in Th17 commitmentFrancis Bonnefoy, Mélanie Couturier, Amandine Clauzon, et al.
Immunology|May 1, 2008
Regulatory T-cell expansion and function do not account for the impaired alloreactivity of ex vivo-expanded T cellsNicolas Montcuquet, Patricia Mercier-Letondal, Sylvain Perruche, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
International Journal of Pharmaceutics|December 9, 2024
Clinically relevant cell culture model of inflammatory bowel diseases for identification of new therapeutic approachesThomas Antoine, Arnaud Béduneau, Claire Chrétien, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|March 14, 2024
Macrophage phenotype is determinant for fibrosis development in keloid diseaseZélie Dirand, Mélissa Maraux, Marion Tissot, et al.
Transplantation|February 24, 2006
Association of mixed hematopoietic chimerism with elevated circulating autoantibodies and chronic graft-versus-host disease occurrenceSylvain Perruche, Aliette Marandin, François Kleinclauss, et al.
Journal of Hematotherapy & Stem Cell Research|September 11, 2003
A single intravenous infusion of apoptotic cells, an alternative cell-based therapy approach facilitating hematopoietic cell engraftment, did not induce autoimmunitySylvain Perruche, François Kleinclauss, Régis Angonin, et al.
Arthritis Research & Therapy|July 3, 2009
Increased production of soluble CTLA-4 in patients with spondylarthropathies correlates with disease activityEric Toussirot, Philippe Saas, Marina Deschamps, et al.
Frontiers in Immunology|February 4, 2022
Pro-Resolving Factor Administration Limits Cancer Progression by Enhancing Immune Response Against Cancer CellsAudrey Wetzel, Francis Bonnefoy, Cécile Chagué, et al.
Blood|October 24, 2002
LF 15-0195 immunosuppressive agent enhances activation-induced T-cell death by facilitating caspase-8 and caspase-10 activation at the DISC levelPatrick Ducoroy, Olivier Micheau, Sylvain Perruche, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|March 6, 2004
[Tolerance in transplantation: potential contribution of haematopoietic transplantation and cell therapy]François Kleinclauss, Hugues Bittard, Sylvain Perruche, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 27, 2011
TGF-beta-exposed plasmacytoid dendritic cells participate in Th17 commitmentFrancis Bonnefoy, Mélanie Couturier, Amandine Clauzon, et al.
Immunology|May 1, 2008
Regulatory T-cell expansion and function do not account for the impaired alloreactivity of ex vivo-expanded T cellsNicolas Montcuquet, Patricia Mercier-Letondal, Sylvain Perruche, et al.
Pageof 6